Document:

exv4w22

 

Exhibit 4.22

Confidential treatment has been requested for certain portions of
this exhibit. The copy filed herewith omits the information subject
to the confidential treatment request. Omissions are designated as
“[*****]” or “*****”. A complete
version of this exhibit has been filed separately with the Commission
pursuant to an application for confidential treatment under
Rule 24b-2 promulgated under the Securities Exchange Act of
1934, as amended.

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	 	 	
AMENDMENT OF SOLICITATION/MODIFICATION
OF CONTRACT
	 	1.
	 	CONTRACT ID CODE

        043085209
	 	 	 	 	 	PAGE

1
	 	OF
	 	PAGES

2
	

	2.	 	
AMENDMENT/MODIFICATION NO.
	 	3.
	 	EFFECTIVE DATE
	 	4.
	 	REQUISITION/PURCHASE REQ. NO.
	 	5.
	 	PROJECT NO. (If applicable)
	 	 	
00004
	 	 	 	See Block 16C.	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	6.	 	
ISSUED BY
	 	CODE   7523
	 	7.
	 	ADMINISTERED BY (If other than Item 6)
	 	 	 	CODE   7523	 	 	 	 	 	 
	 	 	
Centers for Disease Control and
Prevention (CDC)

Procurement and Grants Office (PGO)

2920 Brandywine Road, Rm. 3734

Atlanta, GA 30341-5539	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	8.	 	
NAME AND ADDRESS OF CONTRACTOR
(No., street, county, State and
ZIP Code)
	 	(   )
	 	9A.
	 	AMENDMENT OF SOLICITATION NO.
 

	 	 	
   Acambis, Inc.

   38 Sidney Street

   Cambridge, MA 02139

    

     
	 	 	 	 	 	 	 	 	 	9B.
	 	DATED (See Item 11)
 

	 	 	 	 	 	 	 	 	 	 	 	10A.
	 	MODIFICATION OF CONTRACT/ORDER NO.
	 	 	 	 	 	 	 	 	 	 	 	 	 	200-2002-00004
 

	 	 	 	 	 	 	 	 	 	X
	 	10B.
	 	DATED (See Item 13)
	 	 	 
	CODE      651	 	 	 	FACILITY CODE
	 	 	 	 	 	 	 	November 28, 2001	 	 	 	 	 	 	 	 	 	 
	

	 
	11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	

	o The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers o is extended, o is not extended.
	Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
	(a) By completing Items 8 and 15, and returning      copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer
submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEGMENT
TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT
IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter,
provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
	

	12. ACCOUNTING AND APPROPRIATION DATA (If required)
	Appropriation: 75X0140 Allowance: B2176 OCC: 25.55 CAN: 2921-ATB1 Amount: ****** (Increase)
	

	13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,
	IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
	

	 	 	 	 	 
	(ü)	 	
A.
	 	THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
	

	 	 	
B.
	 	THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET
FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
	

	 	 	
C.
	 	THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
	 	 	 	 	 
	

	X	 	
D.
	 	OTHER (Specify type of modification and authority)
	 	 	 	 	FAR 52.232-22, Limitation of Funds (Apr 1984)
	

	 
	E. IMPORTANT: Contractor x is not, o is required to sign this document and return     copies to the issuing office.
	

	14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
	 
	The purpose of this modification is to incrementally fund Section B, paragraph B.1, of the subject contract.  Page two is attached hereto and made a part hereof. 
	 
	 
	 
	 
	Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
	

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	15A.	 	
NAME AND TITLE OF SIGNER (Type or print)
	 	 	16A.
	 	NAME OF CONTRACTING OFFICER	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	Lorenzo J. Falgiano	 	 	 	 
	

	15B.	 	
CONTRACTOR/OFFEROR
	 	 	 	 	 	16B.
	 	UNITED STATES OF AMERICA	 	 	 	 
	 	 	
 
	 	15C.
	 	DATE SIGNED
	 	 	 	 	 	16C.
	 	DATE SIGNED
	 	 	 	 	 	 	 
	 	BY	 	 	 	 	 	1/31/02
	 	 	
	 	 	 	 	 	 	 	
	 	 	 	 
	 	 	
(Signature of person authorized to sign)
	 	 	 	 	 	 	 	(Signature of Contracting Officer)	 	 	 	 
	

 

 

	 	 	 
	 	 	
Contract No. 200-2002-00004
	 	 	
Modification No. 00004
	 	 	
Page 2 of 2

Section B, paragraph B.1, Consideration, is hereby deleted and the following
substituted therefore:

B.1     352.232-74 CONSIDERATION – FIRM-FIXED PRICE, INCREMENTALLY FUNDED LINE ITEM

	 	 	 	 	 	 	 	 	 
	LINE ITEM	 	SUPPLIES/SERVICES	 	ESTIMATED	 	UNIT	 	EXTENDED
	 	 	 	 	QUANTITY	 	PRICE	 	PRICE
	
	 	
	 	
	 	
	 	

	 	 	 	 	 	 	 	 	 
	0001	 	
Development
Production and
FDA Licensure of
Smallpox Vaccine
	 	22 months
	 	******

per month
	 	******

	 	(a)	 	It is determined that the total price to the Government for full
performance of this line item will be ******
	 
	 	(b)	 	Total funds currently available for payment and allotted to this line
item are ******. For further provisions on funding, see Limitations of
Funds Clause.
	 
	 	(c)	 	It is estimated that the amount currently allotted will cover 12
months of performance of line item 0001 through November 30, 2002.
	 
	 	(d)	 	The Contracting Officer may allot additional funds to the contract
without the concurrence of the Contractor.
	 
	 	(e)	 	Monthly payments will be made upon submission of a properly executed
invoice and submission of the Monthly Progress Report required per
Section C.8 of the Statement of Work.

The contract funded amount is hereby increased from ****** to ******, an
increase of ******, and the period of performance remains unchanged by reason
of this modification.

2exv4w23

 

Exhibit 4.23

Confidential treatment has been requested for certain portions of
this exhibit. The copy filed herewith omits the information subject
to the confidential treatment request. Omissions are designated as
“[*****]” or “*****”. A complete
version of this exhibit has been filed separately with the Commission
pursuant to an application for confidential treatment under
Rule 24b-2 promulgated under the Securities Exchange Act of
1934, as amended.

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	 	 	
AMENDMENT OF SOLICITATION/MODIFICATION
OF CONTRACT
	 	1.
	 	CONTRACT ID CODE

        N/A
	 	 	 	 	 	PAGE

1
	 	OF
	 	PAGES

2
	

	2.	 	
AMENDMENT/MODIFICATION NO.
	 	3.
	 	EFFECTIVE DATE
	 	4.
	 	REQUISITION/PURCHASE REQ. NO.
	 	5.
	 	PROJECT NO. (If applicable)
	 	 	
00005
	 	 	 	See Block 16C.	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	6.	 	
ISSUED BY
	 	CODE  
	 	7.
	 	ADMINISTERED BY (If other than Item 6)
	 	 	 	CODE   	 	 	 	 	 	 
	 	 	
Centers for Disease Control and
Prevention (CDC)

Procurement and Grants Office (PGO)

Acquisition and Assistance Branch B

2920 Brandywine Road, Rm. 3734

Atlanta, GA 30341-5539	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	

	8.	 	
NAME AND ADDRESS OF CONTRACTOR
(No., street, county, State and
ZIP Code)
	 	(   )
	 	9A.
	 	AMENDMENT OF SOLICITATION NO.
 

	 	 	
   Acambis, Inc.

   38 Sidney Street

   Cambridge, MA 02139

    

     
	 	 	 	 	 	 	 	 	 	9B.
	 	DATED (See Item 11)
 

	 	 	 	 	 	 	 	 	 	 	 	10A.
	 	MODIFICATION OF CONTRACT/ORDER NO.
	 	 	 	 	 	 	 	 	 	 	 	 	 	200-2002-00004
 

	 	 	 	 	 	 	 	 	 	X
	 	10B.
	 	DATED (See Item 13)
	 	 	 
	CODE      651	 	 	 	FACILITY CODE
	 	 	 	 	 	 	 	11/28/2001	 	 	 	 	 	 	 	 	 	 
	

	 
	11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
	

	o The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers o is extended, o is not extended.
	Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:
	(a) By completing Items 8 and 15, and returning      copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer
submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEGMENT
TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT
IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter,
provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
	

	12. ACCOUNTING AND APPROPRIATION DATA (If required)
	Appropriation: 75X0140 Allowance: 3-B2316 OCC: 2555 CAN: 3921-ATB1 Amt: ****** (Increase)
	

	13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,
	IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
	

	 	 	 	 	 
	(ü)	 	
A.
	 	THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
	

	 	 	
B.
	 	THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET
FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
	

	X	 	
C.
	 	THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
	 	 	 	 	Mutual Agreement of both parties
	

	 	 	
D.
	 	OTHER (Specify type of modification and authority)
	 	 	 	 	 
	

	 
	E. IMPORTANT: Contractor o is not, x is required to sign this document and return  2 copies to the issuing office.
	

	14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
	 
	The purpose of this modification is to incrementally fund Section B, paragraph B.1, and modify Section H, paragraph H.27, of the subject contract.
	 
	Also, by signing this modification, the Contractor agrees to allow the government to modify Delivery Order 00001 of the subject contract, on a one time basis after the date of this modification, to increase the number of doses ordered by 15-20 million additional doses of vaccine at the price of ****** per dose.
	 
	Page two is attached hereto and made a part of hereof. 
	 
	 
	 
	 
	Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
	

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	15A.	 	
NAME AND TITLE OF SIGNER (Type or print)

******
	 	 	16A.
	 	NAME OF CONTRACTING OFFICER	 	 	 	 
	 	 	******	 	 	 	 	 	 	 	Lorenzo J. Falgiano	 	 	 	 
	

	15B.	 	
CONTRACTOR/OFFEROR
	 	 	 	 	 	16B.
	 	UNITED STATES OF AMERICA	 	 	 	 
	 	 	
 
	 	15C.
	 	DATE SIGNED
	 	 	 	 	 	16C.
	 	DATE SIGNED
	 	 	 	 	 	 	01/03/03
	 	BY	 	 	 	 	 	JAN 03 2003
	 	 	
	 	 	 	 	 	 	 	
	 	 	 	 
	 	 	
(Signature of person authorized to sign)
	 	 	 	 	 	 	 	(Signature of Contracting Officer)	 	 	 	 
	

 

 

	 	 	 
	 	 	
Contract No. 200-2002-00004
	 	 	
Modification No. 00005

	1.	 	Section B, paragraph B.1, Consideration, is hereby deleted and the
following substituted therefore:

B.1     352.232 CONSIDERATION, FIRM-FIXED PRICE, INCREMENTALLY FUNDED LINE ITEM

	 	 	 	 	 	 	 	 	 
	LINE ITEM	 	SUPPLIES/SERVICES	 	ESTIMATED	 	UNIT	 	EXTENDED
	 	 	 	 	QUANTITY	 	PRICE	 	PRICE
	
	 	
	 	
	 	
	 	

	 	 	 	 	 	 	 	 	 
	0001	 	
Development
Production and
FDA Licensure of
Smallpox Vaccine
	 	22 months
	 	******
	 	******

	 	(a)	 	It is determined that the total price to the Government for full
performance of this line item will be ******
	 
	 	(b)	 	Total funds currently available for payment and allotted to this line
item are ******. For further provisions on funding, see Limitations of
Funds Clause.
	 
	 	(c)	 	It is estimated that the amount currently allotted will cover 14
months of performance of line item 0001 through January 31, 2003.
	 
	 	(d)	 	The Contracting Officer may allot additional funds to the contract
without the concurrence of the Contractor.
	 
	 	(e)	 	Monthly payments will be made upon submission of a properly executed
invoice and submission of the Monthly Progress Report required per
Section C.8 of the Statement of Work.

	2.	 	Section H, paragraph H.27, Rights of the Contractor to Market Smallpox
Vaccine, is hereby deleted and the following substituted therefore:
	 
		 	H. 27   RIGHTS OF THE CONTRACTOR TO MARKET SMALLPOX VACCINE
	 
	 	 	The Contractor will hold exclusive commercial rights to the smallpox
vaccine developed under this contract. The Contractor is not restricted
in marketing this vaccine outside of the United States and its possessions
provided that such marketing does not interfere with performance under
this Contract. The Contractor is permitted to market the smallpox vaccine
developed under this contract in the United States and its possessions
provided that such marketing (1) is consistent with the recommendations
for the smallpox vaccine of the CDC’s Advisory Committee on Immunization
Practices (ACIP), and (2) does not interfere with performance under this
contract.

2

 

The contract funded amount is hereby increased from ****** to ******, an
increase of ****** and the period of performance remains unchanged by reason of
this modification.

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00054-of-00352.parquet"}]]